How to Buy Health Catalyst Stock
Health Catalyst Inc
Health Catalyst, Inc. equips healthcare providers with crucial data and analytical technologies, alongside specialized services.
Health Catalyst stock last closed at $1.70, up 0.59% from the previous day, and has decreased 49.7% in one year. It has underperformed other stocks in the Health Information Services industry by 0.12 percentage points. Health Catalyst stock is currently +78.01% from its 52-week low of $0.96, and -52.97% from its 52-week high of $3.62.
As of Sep 8, 2026, there are 75.26M HCAT shares outstanding. The market capitalization of HCAT is $127.94M. In the last 24 hours, 691,000 HCAT shares were traded.
How to Buy Health Catalyst Stock
Not sure how to invest in Health Catalyst stock? Here's how.
- Choose where to buy Health Catalyst stock: You need to choose a stock brokerage, but don't worry - we've researched dozens of online stock brokerages and apps to help you determine where to buy Health Catalyst stock.
- Sign up for a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Put funds into your brokerage account: Choose your payment method and add your info.
- Evaluate Health Catalyst stock: The Health Catalyst ticker symbol is HCAT. Is Health Catalyst stock a good investment? Should you buy shares of HCAT? How do HCAT's underlying business fundamentals look? Do top analysts think Health Catalyst is a good buy? Why has HCAT's stock price moved recently? (Hint: Our stock research tools can help you evaluate if HCAT is a good stock to buy).
- Place your HCAT purchase: Decide if you will purchase HCAT shares at the current market price or use a limit order to purchase HCAT shares at a particular price.
- Get the latest news on your investment in HCAT: Create a watchlist to keep tabs on your investment in Health Catalyst shares.
Step 1: Choose where to buy Health Catalyst stock
You need an online brokerage account in order to access the NASDAQ market and buy HCAT stock.
Our recommended brokerage: eToro
Based on our analysis, eToro is the best brokerage. Here's why:
- Invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to world financial markets: From Tech to Healthcare, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading stock exchanges.
- Social investing: eToro boasts a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by creating an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've chosen the right brokerage, you need to fill out some personal details so you can invest in HCAT stock today.
How to Create a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal details to start a new trading account.
- Submit your details by pressing the "Create Account" button. Get started with eToro today
Step 3: Put funds into your brokerage account
Now that you've filled out your info on one of the best stock market apps, your next step is to transfer the money for your investment:
Check out the tutorial below if you need help depositing money into your investment account.
Step 4: Evaluate Health Catalyst stock
Once you have figured out the best place to buy Health Catalyst stock, it's absolutely critical to analyze their stock prior to investing, so you truly comprehend the risk and upside.
Health Catalyst quick stats
Health Catalyst Overview
WallStreetZen was created to help part-time investors do better fundamental analysis.
You can see all of the due diligence checks on HCAT's stock page.
Is HCAT stock undervalued?
You can use many financial metrics, analyses, models, and charts to gauge HCAT's intrinsic value.
Using relative valuations ratios:
- HCAT could be undervalued based on its P/B ratio of 1.27x, relative to Health Information Services industry P/B ratio of 3.84x
You can do additional valuation research on HCAT's stock here.
HCAT Financial Health Summary
Passed Financial Due Diligence Checks:
- There are more short-term assets than long-term liabilities on the HCAT balance sheet.
- There are more short-term assets than short-term liabilities on the HCAT balance sheet.
Failed Financial Due Diligence Checks:
- HCAT has a relatively high debt to equity ratio of 2.56.
- Total HCAT debt is higher than 5 years ago, relative to shareholder equity.
- HCAT earnings of -$246.55M is not sufficient to cover its interest payments.
- HCAT profit margin has gone down from -31.7% to -90.6% in the past year.
- HCAT's operating cash flow of $28.23M allows it to safely service it's debt of $169.98M.
Do Wall Street analysts think it's a good time to buy Health Catalyst stock
Out of 6 Wall Street analysts who track HCAT, the consensus analyst rating on HCAT is a Hold
It's important to keep in mind that analyst forecasts are not stock recommendations, nor are they financial advice.
Latest HCAT Analyst Upgrades/Downgrades
Sarah James, a bottom 1% analyst from Cantor Fitzgerald maintains HCAT with a hold rating and lowers their HCAT price target from $4.00 to $3.00, on Mar 13, 2026.
You can dig deeper into what analysts are projecting on the Health Catalyst stock forecast page.
HCAT Technicals
How are HCAT Revenues/Earnings doing?
Last year, HCAT revenue was $292.25M. Over the past five year, HCAT's revenue has gone up by 6.24% per year. This was slower than the Health Information Services industry average of 22.07%.
Dive into HCAT's earnings and revenue performance here.
Are HCAT executives and large shareholders buying or selling the stock?
In the last year, executives and large shareholders at HCAT have sold more shares than they have bought.
Benjamin Albert, CEO of HCAT, was the latest HCAT insider to sell. They sold $546.98 worth of HCAT stock on Sep 1, 2026.
Get more info about who owns HCAT stock here.
Does HCAT stock generate passive income?
No, Health Catalyst doesn't provide an income stream by paying out dividends.
Get opinions from other traders
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Place your HCAT purchase
You have two main types of orders:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are generally fine. - Limit order: A limit order allows you to buy or sell a security at a specific price (or better).
If you want to ensure you're buying or selling at a specific dollar amount limit, place a limit order.
Hit the Open button and eToro will execute the order.
If you require additional info about investing in stocks on eToro, click the helpful video below:
Step 6: Get the latest news on your investment in HCAT
Now that you own some HCAT shares, you'll want to stay up-to-date on your new shares.
Start a watchlist to get the latest updates about your HCAT stock.
HCAT Feed
How to Buy Stock in Health Catalyst
To summarize, here are the 6 steps to buy Health Catalyst stock:
- Choose where to buy Health Catalyst stock
- Sign up for a brokerage account
- Put funds into your brokerage account
- Evaluate Health Catalyst stock
- Place your HCAT purchase
- Get the latest news on your investment in HCAT
If you are looking for a brokerage account, eToro is our recommended venue.
Get Started with eToro TodayIf you want to track your new investment in Health Catalyst, add HCAT to your watchlist below.
More Stock Buying Guides You May Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.